Concepedia

Peter W. R. Caulkett

PW

Statistics

Publications

10

Citations

799

H-Index

10

Active since

1977

Affiliations

AstraZeneca (United Kingdom)(Current)

Bangor University

Peter W. R. Caulkett is an author at AstraZeneca (United Kingdom) specializing in medicinal chemistry, chemistry, and organic chemistry.

Publications per year

1977–2015

10

Publications

10

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A<sub>2a</sub>selective adenosine receptor antagonist

Simon M. Poucher, J R Keddie, Parminder Singh et al. · British Journal of Pharmacology · 1995 · 364 citations · Full text

, , +8

Synthesis and applications of C2-symmetric guanidine bases

Matthew T. Allingham, Andrew Howard‐Jones, P. J. Murphy et al. · Tetrahedron Letters · 2003 · 133 citations

, , +12

Design of a potent, soluble glucokinase activator with excellent in vivo efficacy

Darren McKerrecher, Joanne V. Allen, Peter W. R. Caulkett et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 85 citations · Full text

, , +6

Discovery, synthesis and biological evaluation of novel glucokinase activators

Darren McKerrecher, Joanne V. Allen, Suzanne S. Bowker et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 55 citations · Full text

, , +9

Synthesis of a Novel <i>C</i><i><sub>2</sub></i>-Symmetric Guanidine Base

Andrew Howard‐Jones, P. J. Murphy, Dafydd A. Thomas et al. · The Journal of Organic Chemistry · 1999 · 45 citations

, , +6

1–5 of 10